Yi Yang

3.1k total citations · 1 hit paper
140 papers, 2.1k citations indexed

About

Yi Yang is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yi Yang has authored 140 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 36 papers in Surgery and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yi Yang's work include Trauma Management and Diagnosis (15 papers), Cancer Immunotherapy and Biomarkers (10 papers) and MicroRNA in disease regulation (9 papers). Yi Yang is often cited by papers focused on Trauma Management and Diagnosis (15 papers), Cancer Immunotherapy and Biomarkers (10 papers) and MicroRNA in disease regulation (9 papers). Yi Yang collaborates with scholars based in China, United States and Netherlands. Yi Yang's co-authors include Shun Lü, Jueheng Wu, Jie Yuan, Mengfeng Li, Lishan Fang, Junchao Cai, Liliang Xia, Ying Wang, Chengcheng Yao and Yongqiang Zhu and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Yi Yang

123 papers receiving 2.1k citations

Hit Papers

The Diversity of Gut Microbiome is Associated With Favora... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC
    2019 396 citations Yueping Jin, Hui Dong et al. Journal of Thoracic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Yang China 22 1.1k 626 499 329 320 140 2.1k
Liang Zhou China 28 1.7k 1.5× 615 1.0× 821 1.6× 398 1.2× 363 1.1× 166 3.0k
Rui Huang China 28 1.2k 1.0× 673 1.1× 724 1.5× 335 1.0× 482 1.5× 178 2.4k
Ninghan Feng China 27 1.4k 1.2× 401 0.6× 575 1.2× 161 0.5× 271 0.8× 126 2.2k
Jian Pan China 29 1.3k 1.1× 427 0.7× 461 0.9× 239 0.7× 312 1.0× 140 2.3k
Ko‐Jiunn Liu Taiwan 26 1.0k 0.9× 473 0.8× 371 0.7× 353 1.1× 245 0.8× 65 2.4k
Cong Wang China 28 1.4k 1.2× 483 0.8× 472 0.9× 228 0.7× 318 1.0× 100 2.4k
Jin‐Yeong Han South Korea 29 772 0.7× 437 0.7× 256 0.5× 328 1.0× 288 0.9× 149 2.7k
Ting Jin China 25 926 0.8× 315 0.5× 572 1.1× 289 0.9× 288 0.9× 89 1.9k
Shiming Yang China 29 1.6k 1.4× 413 0.7× 561 1.1× 240 0.7× 174 0.5× 66 2.5k

Countries citing papers authored by Yi Yang

Since Specialization
Citations

This map shows the geographic impact of Yi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Yang more than expected).

Fields of papers citing papers by Yi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Yang. The network helps show where Yi Yang may publish in the future.

Co-authorship network of co-authors of Yi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Yang. A scholar is included among the top collaborators of Yi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Yang. Yi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Du, Lillian, Lili Liang, Yi Yang, et al.. (2025). Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease. mSystems. 10(4). e0114824–e0114824. 7 indexed citations
3.
4.
5.
Yang, Yi, et al.. (2024). Recombinant human amelogenin promotes wound healing by enhancing angiogenesis. Biochemical and Biophysical Research Communications. 734. 150462–150462. 3 indexed citations
6.
Yang, Yi, et al.. (2024). Design and Evaluation of Peptide Inhibitors Targeting the Dimerization of SARS‐CoV‐2 Main Protease. ChemBioChem. 26(1). e202400688–e202400688. 1 indexed citations
7.
Zhao, Haobin, Yuxiang Ma, Xiao‐Ming Meng, et al.. (2024). 605O YL201, a novel B7H3-targeting antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors: Results from a first-in-human phase I study. Annals of Oncology. 35. S485–S485. 4 indexed citations
8.
Yang, Yi, et al.. (2023). Case report of severe coronary artery tortuosity with coexisting connective tissue disease. Annals of Noninvasive Electrocardiology. 28(4). e13052–e13052. 1 indexed citations
9.
Li, Yahui, Q Zhang, Yuyu Zhang, et al.. (2023). Improved analysis ZIC-HILIC-HCD-Orbitrap method for mapping the glycopeptide by mass spectrometry. Journal of Chromatography B. 1228. 123852–123852. 1 indexed citations
10.
Li, Shuangli, Xue Huang, Yi Yang, et al.. (2023). Design and evaluation of tadpole-like conformational antimicrobial peptides. Communications Biology. 6(1). 1177–1177. 7 indexed citations
11.
Li, Xin, Xia Qin, Miao Yan, et al.. (2023). Germline Neurofibromin 1 mutation enhances the anti‐tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicity. British Journal of Haematology. 202(2). 328–343. 4 indexed citations
12.
13.
Li, Huifang, et al.. (2022). The efficacy of Shenghua Decoction supplementation after early medical abortion: A meta-analysis of randomized controlled trials. Complementary Therapies in Medicine. 69. 102848–102848. 2 indexed citations
14.
Lü, Shun, Yongfeng Yu, & Yi Yang. (2019). Retrospect and Prospect for Lung Cancer in China: Clinical Advances of Immune Checkpoint Inhibitors. The Oncologist. 24(S1). S21–S30. 27 indexed citations
15.
Cui, Yu, Yi Yang, Liang Ren, et al.. (2019). miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/β-Catenin Signaling Pathway. Cancer Biotherapy and Radiopharmaceuticals. 34(7). 472–479. 23 indexed citations
16.
Jin, Yueping, Hui Dong, Liliang Xia, et al.. (2019). The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC. Journal of Thoracic Oncology. 14(8). 1378–1389. 396 indexed citations breakdown →
17.
Niu, Xiaomin, et al.. (2017). P1.02-056 Tumor Heterogeneity in Lesion Specific Response Creates ROS1 Fusion Mediating Resistance to Gefitinib in EGFR 19 Deletion Lung Adenocarcinoma. Journal of Thoracic Oncology. 12(1). S521–S522. 1 indexed citations
18.
Cai, Junchao, Lishan Fang, Yongbo Huang, et al.. (2013). miR-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non–Small Cell Lung Cancer. Cancer Research. 73(17). 5402–5415. 176 indexed citations
19.
Cai, Junchao, Hongyu Guan, Lishan Fang, et al.. (2013). MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis. Journal of Clinical Investigation. 123(2). 566–79. 305 indexed citations
20.
Gallis, Byron, David R. Goodlett, Yi Yang, et al.. (2013). Effects of transferrin conjugates of artemisinin and artemisinin dimer on breast cancer cell lines.. Anticancer Research. 33(1). 123–32. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liang Zhou Breakdown of academic impact, for papers by Rui Huang Breakdown of academic impact, for papers by Ninghan Feng Breakdown of academic impact, for papers by Jian Pan Breakdown of academic impact, for papers by Ko‐Jiunn Liu Breakdown of academic impact, for papers by Cong Wang Breakdown of academic impact, for papers by Jin‐Yeong Han Breakdown of academic impact, for papers by Ting Jin Breakdown of academic impact, for papers by Shiming Yang
Rankless by CCL
2026